UiPath Inc. (PATH) surged 23.79%, climbing $3.54 to $18.40, after announcing its entry into the Veeva AI Partner Program, which will integrate UiPath's automation platform with Veeva's AI-powered testing tools to deliver advanced agentic testing capabilities for life sciences customers.
Investors reacted enthusiastically to the partnership, viewing it as a strategic expansion of UiPath's automation footprint into regulated industries and a potential catalyst for renewed growth in enterprise adoption of its platform.
On the day of the announcement, PATH recorded unusually heavy trading volume as the market digested the partnership news. The stock's 52-week range is approximately $11.05 - $21.50.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.